Clinical Trials Browser

Phase 1/2 × OTHER × Maximum Tolerated Dose × Clear all

NCT05212012 2025-10-03

MEFOX

Phase 1/2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT02477215 2020-10-22

Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma

Phase 1/2 Completed

38 enrolled 18 charts

Multiple Myeloma